image

The best stocks to buy since 1993

Latest issue now available

Servelec - Firing on all cylinders

October 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SERV
  • Price:
  • 273p
Servelec's H1 results show that revenues increased 29% to £25m with 12% growth in pretax profit to £5m. Servelec is clearly firing on all cylinders with order intake up 82% to £29m, which underpins prospects.  The Healthcare side had a very successful H1 although this wasn't borne out in results. To recap, the division supplies patient administration systems under the National Programme (under the current contracts with BT) but as the BT contracts expire  and trusts re-procure, Servelec is becoming a direct supplier. Divisional H1 sales were up 5% to £7.4m and operating profit was up 3% to £3.3m but the period saw 11 contracts won and these are only going live between now and the end ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe